SCHEMBL3495890

SCHEMBL3495890

CCCCCCCCCCNC(=O)C1C2CCC(O2)C1C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 1/20 0.51
LMNA P02545 2/20 0.50
TFPI2 P48307 2/20 0.50
ALDH1A1 P00352 1/20 0.50
MAPK1 P28482 1/20 0.50
PRCP P42785 1/20 0.50
KDM4E B2RXH2 1/20 0.50
GMNN O75496 1/20 0.50
PMP22 Q01453 1/20 0.50
TP53 P04637 1/20 0.50
TSHR P16473 1/20 0.50
NFKB1 P19838 1/20 0.50
THPO P40225 1/20 0.50
PPM1B O75688 3/20 0.49
PTPN1 P18031 3/20 0.49
PPP1CC P36873 2/20 0.49
L3MBTL1 Q9Y468 1/20 0.48
GNAI3 P08754 1/20 0.48
GNAO1 P09471 1/20 0.48
GNAI1 P63096 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13311753 1.00 NAAA (0.51) NAAALMNATFPI2ALDH1A1MAPK1
SCHEMBL3495465 1.00 NAAA (0.51) NAAALMNATFPI2ALDH1A1MAPK1
SCHEMBL3493746 1.00 NAAA (0.51) NAAALMNATFPI2ALDH1A1MAPK1
SCHEMBL3494796 1.00 NAAA (0.51) NAAALMNATFPI2ALDH1A1MAPK1
SCHEMBL3495818 1.00 NAAA (0.51) NAAALMNATFPI2ALDH1A1MAPK1
SCHEMBL13311513 1.00 NAAA (0.51) NAAALMNATFPI2ALDH1A1MAPK1
SCHEMBL3875657 1.00 NAAA (0.51) NAAALMNATFPI2ALDH1A1MAPK1
SCHEMBL13311750 1.00 NAAA (0.51) NAAALMNATFPI2ALDH1A1MAPK1
SCHEMBL3495237 1.00 NAAA (0.51) NAAALMNATFPI2ALDH1A1MAPK1
SCHEMBL3497074 0.98 LMNA (0.52) NAAALMNATFPI2ALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100137294-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR CONTROLLING INVERTEBRATE PESTS GENETIC TECHNOLOGIES LIMITED (AU) 2010-06-03 US claimed
EP-2086534-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR CONTROLLING INVERTEBRATE PESTS Genetic Technologies Limited (AU) 2009-08-12 EP claimed
WO-2008058342-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR CONTROLLING INVERTEBRATE PESTS GENETIC TECHNOLOGIES LIMITED (AU) 2008-05-22 WO claimed
US-20100137294-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR CONTROLLING INVERTEBRATE PESTS GENETIC TECHNOLOGIES LIMITED (AU) 2010-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137294-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR CONTROLLING INVERTEBRATE PESTS PPP1R10, TASP1, PPP5C NAAA 3097/4885LMNA 4332/4885TFPI2 1086/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.